<DOC>
	<DOCNO>NCT01776905</DOCNO>
	<brief_summary>The objective clinical trial determine whether Photoacoustic flow cytometry ( PAFC ) -based prototype device detect circulate tumor cell ( CTCs ) blood melanoma patient vivo , real time , detection limit least one order magnitude detection limit currently exist ex vivo method .</brief_summary>
	<brief_title>In Vivo Real-time Detection Circulating Melanoma Cells</brief_title>
	<detailed_description>Study Population : Approximately 80 subject consent order achieve enrollment goal 75 subject institution three cohort follow : 1 . Cohort # 1 consist fifteen healthy control subject , ten Caucasian five African-American . Subjects cohort # 1 used address calibration goal Specific Aim # 1 . 2 . Cohort # 2 consist 30 subject advanced-stage melanoma recruit Medical Oncology clinic UAMS , advance stage define Stages III IV . Subjects cohort # 2 used address validation goal Specific Aim # 2 . Approximately half 30 advanced-stage subject Stage III half Stage IV . 3 . Cohort # 3 consist 30 subject early-stage melanoma recruit Surgical Oncology clinic UAMS , early stage define Stages I II . Subjects cohort # 3 used address detection goal Specific Aim # 3 . Approximately 10 30 early-stage subject Stage I approximately 20 Stage II .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Age 18 80 year Histological document diagnosis melanoma Signed informed consent form approve University Arkansas Medical Sciences ( UAMS ) Institutional Review Board ( IRB ) Must able sit still 90 minute Active infection Current significant medical surgical condition determine Investigator Diagnosis evidence organic brain syndrome Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Cancer</keyword>
</DOC>